Follow us on:

Sativa Wellness Group seed to shelf CBD journey that the market can rely on (Interview)

Sativa Wellness Group Inc. (AQSE:SWEL / CNSX:SWEL) Executive Chairman Geremy Thomas joins DirectorsTalk to discuss its operations meeting the requirements of Good Manufacturing Practice and Good Hygiene Practice standards for food manufacturing. Geremy explains what this means for the company, the impact this has on the Novel Foods accreditation and now with David Beckham as a competitor, how he feels about that.

Sativa Wellness Group goal is to build Europe’s leading CBD Wellness brands, to meet today’s fast evolving consumer expectations. Through full vertical integration of their supply chain, they plan to become one of the premier low-cost producers and high-quality distributors of CBD wellness products in Europe.

Find more news, interviews, share price & company profile here for:Goodbody Health

Share this interview

Other Interviews

More News

Sativa Wellness Group offer 2 and 8 day quarantine tests for travellers April 6, 2021
Sativa Wellness Group Million Pound Testing Milestone March 10, 2021
Sativa Wellness Group well positioned to capitalise on expanding CBD marketplace March 5, 2021
Sativa Wellness Group CBD Therapeutics Business Achieves the Highest Food Safety Standards March 1, 2021
Sativa Wellness Group “shares very attractive when compared to Cellular Goods and Kanabo” February 26, 2021
Sativa Wellness Group launches 8 more COVID testing facilities February 22, 2021
Sativa Wellness Group Novel food application significant milestone February 15, 2021
Sativa Wellness Group Business Update January 26, 2021
Sativa Wellness qualifies for the “Apex” segment of the AQSE Growth Market December 15, 2020
Sativa Wellness Group CBD and cannabis regulatory progress December 14, 2020

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.